Home LiteratureArticle Details
PMID: 12101223 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S. Review

Pondering the promyelocytic leukemia protein (PML) puzzle: possible functions for PML nuclear bodies.

Molecular and cellular biology ·Vol. 22 ·No. 15 ·2002-08-00 ·Pages 5259-69

Borden KL

Abstract

暂无摘要

MeSH Terms
Animals Cell Division/physiology Cell Nucleus/metabolism Cell Nucleus Structures/physiology Cytoplasm/metabolism DNA Replication/physiology Gene Expression Regulation/physiology Humans Leukemia, Promyelocytic, Acute/metabolism Macromolecular Substances Neoplasm Proteins/metabolism Nuclear Proteins Organelles/physiology Promyelocytic Leukemia Protein Protein Isoforms/metabolism Transcription Factors/metabolism Tumor Suppressor Proteins Zinc Fingers
Chemicals
Macromolecular Substances Neoplasm Proteins Nuclear Proteins Promyelocytic Leukemia Protein Protein Isoforms Transcription Factors Tumor Suppressor Proteins PML protein, human
Authors & Affiliations
1 authors, click to expand affiliations / ORCID
Borden Katherine L B
Structural Biology Program, Department of Physiology and Biophysics, Mount Sinai School of Medicine, New York University, One Gustave L. Levy Place, New York, NY 10029, USA. kathy@physbio.mssm.edu
References (107)
107 references, click to expand
  1. Identification of a novel nuclear domain.
    J Cell Biol. 1991 Mar;112(5):785-95 PMID: 1999457
  2. Structure, localization and transcriptional properties of two classes of retinoic acid receptor alpha fusion proteins in acute promyelocytic leukemia (APL): structural similarities with a new family of oncoproteins.
    EMBO J. 1992 Feb;11(2):629-42 PMID: 1311253
  3. The 35-kDa mammalian splicing factor SC35 mediates specific interactions between U1 and U2 small nuclear ribonucleoprotein particles at the 3' splice site.
    Proc Natl Acad Sci U S A. 1992 Mar 1;89(5):1725-9 PMID: 1531875
  4. Alternative splicing of PML transcripts predicts coexpression of several carboxy-terminally different protein isoforms.
    Oncogene. 1992 Jun;7(6):1083-91 PMID: 1594241
  5. Ras mediates translation initiation factor 4E-induced malignant transformation.
    Genes Dev. 1992 Sep;6(9):1631-42 PMID: 1516827
  6. A monoclonal antibody recognizing nuclear matrix-associated nuclear bodies.
    J Cell Sci. 1992 Apr;101 ( Pt 4):773-84 PMID: 1527179
  7. A fraction of the mRNA 5' cap-binding protein, eukaryotic initiation factor 4E, localizes to the nucleus.
    Proc Natl Acad Sci U S A. 1992 Oct 15;89(20):9612-6 PMID: 1384058
  8. Sequence-specific binding of transfer RNA by glyceraldehyde-3-phosphate dehydrogenase.
    Science. 1993 Jan 15;259(5093):365-8 PMID: 8420004
  9. Distribution of snRNPs, splicing factor SC-35 and actin in interphase nuclei: immunocytochemical evidence for differential distribution during changes in functional states.
    J Cell Sci. 1993 Jun;105 ( Pt 2):347-57 PMID: 8408269
  10. A novel macromolecular structure is a target of the promyelocyte-retinoic acid receptor oncoprotein.
    Cell. 1994 Jan 28;76(2):333-43 PMID: 8293467
  11. Retinoic acid regulates aberrant nuclear localization of PML-RAR alpha in acute promyelocytic leukemia cells.
    Cell. 1994 Jan 28;76(2):345-56 PMID: 8293468
  12. Initiation factor eIF-4E of Saccharomyces cerevisiae. Distribution within the cell, binding to mRNA, and consequences of its overproduction.
    J Biol Chem. 1994 Feb 25;269(8):6117-23 PMID: 8119957
  13. Glyceraldehyde-3-phosphate dehydrogenase selectively binds AU-rich RNA in the NAD(+)-binding region (Rossmann fold).
    J Biol Chem. 1995 Feb 10;270(6):2755-63 PMID: 7531693
  14. PML nuclear bodies are general targets for inflammation and cell proliferation.
    Cancer Res. 1995 Apr 1;55(7):1590-7 PMID: 7882370
  15. Characterization of a new monoclonal antibody (PG-M3) directed against the aminoterminal portion of the PML gene product: immunocytochemical evidence for high expression of PML proteins on activated macrophages, endothelial cells, and epithelia.
    Blood. 1995 Apr 1;85(7):1871-80 PMID: 7535592
  16. The solution structure of the RING finger domain from the acute promyelocytic leukaemia proto-oncoprotein PML.
    EMBO J. 1995 Apr 3;14(7):1532-41 PMID: 7729428
  17. Modulation of CREB binding protein function by the promyelocytic (PML) oncoprotein suggests a role for nuclear bodies in hormone signaling.
    Proc Natl Acad Sci U S A. 1999 Mar 16;96(6):2627-32 PMID: 10077561
  18. Deconstructing a disease: RARalpha, its fusion partners, and their roles in the pathogenesis of acute promyelocytic leukemia.
    Blood. 1999 May 15;93(10):3167-215 PMID: 10233871
  19. P/CAF associates with cyclin D1 and potentiates its activation of the estrogen receptor.
    Proc Natl Acad Sci U S A. 1999 May 11;96(10):5382-7 PMID: 10318892
  20. Promyelocytic leukemia (PML) nuclear bodies are protein structures that do not accumulate RNA.
    J Cell Biol. 2000 Jan 24;148(2):283-92 PMID: 10648561
  21. RING domains: master builders of molecular scaffolds?
    J Mol Biol. 2000 Feb 4;295(5):1103-12 PMID: 10653689
  22. The lymphocytic choriomeningitis virus RING protein Z associates with eukaryotic initiation factor 4E and selectively represses translation in a RING-dependent manner.
    J Virol. 2000 Apr;74(7):3293-300 PMID: 10708446
  23. The promyelocytic leukemia (PML) protein suppresses cyclin D1 protein production by altering the nuclear cytoplasmic distribution of cyclin D1 mRNA.
    Oncogene. 2000 Mar 23;19(13):1623-34 PMID: 10763819
  24. Nuclear structure in normal and Bloom syndrome cells.
    Proc Natl Acad Sci U S A. 2000 May 9;97(10):5214-9 PMID: 10779560
  25. Review: properties and assembly mechanisms of ND10, PML bodies, or PODs.
    J Struct Biol. 2000 Apr;129(2-3):278-87 PMID: 10806078
  26. Nuclear distribution of prothymosin alpha and parathymosin: evidence that prothymosin alpha is associated with RNA synthesis processing and parathymosin with early DNA replication.
    Exp Cell Res. 2000 May 25;257(1):152-61 PMID: 10854063
  27. PML regulates p53 acetylation and premature senescence induced by oncogenic Ras.
    Nature. 2000 Jul 13;406(6792):207-10 PMID: 10910364
  28. PML is induced by oncogenic ras and promotes premature senescence.
    Genes Dev. 2000 Aug 15;14(16):2015-27 PMID: 10950866
  29. Combinatorial roles of the nuclear receptor corepressor in transcription and development.
    Cell. 2000 Sep 15;102(6):753-63 PMID: 11030619
  30. Cajal bodies: the first 100 years.
    Annu Rev Cell Dev Biol. 2000;16:273-300 PMID: 11031238
  31. SUMO--nonclassical ubiquitin.
    Annu Rev Cell Dev Biol. 2000;16:591-626 PMID: 11031248
  32. p53 binds selectively to the 5' untranslated region of cdk4, an RNA element necessary and sufficient for transforming growth factor beta- and p53-mediated translational inhibition of cdk4.
    Mol Cell Biol. 2000 Nov;20(22):8420-31 PMID: 11046139
  33. ALT-associated PML bodies are present in viable cells and are enriched in cells in the G(2)/M phase of the cell cycle.
    J Cell Sci. 2000 Dec;113 Pt 24:4577-85 PMID: 11082050
  34. Visualization of gene activity in living cells.
    Nat Cell Biol. 2000 Dec;2(12):871-8 PMID: 11146650
  35. Exploring (novel) gene expression during retinoid-induced maturation and cell death of acute promyelocytic leukemia.
    Semin Hematol. 2001 Jan;38(1):71-85 PMID: 11172541
  36. PML and COP1--two proteins with much in common.
    Trends Biochem Sci. 2001 Jan;26(1):18-20 PMID: 11165511
  37. Role of the promyelocytic leukemia protein PML in the interferon sensitivity of lymphocytic choriomeningitis virus.
    J Virol. 2001 Jul;75(13):6204-8 PMID: 11390623
  38. Immunohistochemical expression and pathogenesis of BLM in the human brain and visceral organs.
    Neuropathology. 2001 Jun;21(2):123-8 PMID: 11396677
  39. The human interferon- and estrogen-regulated ISG20/HEM45 gene product degrades single-stranded RNA and DNA in vitro.
    Biochemistry. 2001 Jun 19;40(24):7174-9 PMID: 11401564
  40. Role of promyelocytic leukemia (PML) sumolation in nuclear body formation, 11S proteasome recruitment, and As2O3-induced PML or PML/retinoic acid receptor alpha degradation.
    J Exp Med. 2001 Jun 18;193(12):1361-71 PMID: 11413191
  41. Role of PML and PML-RARalpha in Mad-mediated transcriptional repression.
    Mol Cell. 2001 Jun;7(6):1233-43 PMID: 11430826
  42. Cytoplasmic recruitment of INI1 and PML on incoming HIV preintegration complexes: interference with early steps of viral replication.
    Mol Cell. 2001 Jun;7(6):1245-54 PMID: 11430827
  43. PML mediates the interferon-induced antiviral state against a complex retrovirus via its association with the viral transactivator.
    EMBO J. 2001 Jul 2;20(13):3495-505 PMID: 11432836
  44. Induction of the PML protein by interferons in normal and APL cells.
    Leukemia. 1995 Dec;9(12):2027-33 PMID: 8609713
  45. Transcriptional induction of the PML growth suppressor gene by interferons is mediated through an ISRE and a GAS element.
    Oncogene. 1995 Dec 21;11(12):2565-73 PMID: 8545113
  46. Analysis of the growth and transformation suppressor domains of promyelocytic leukemia gene, PML.
    J Biol Chem. 1996 Jan 5;271(1):130-5 PMID: 8550548
  47. Translation initiation of ornithine decarboxylase and nucleocytoplasmic transport of cyclin D1 mRNA are increased in cells overexpressing eukaryotic initiation factor 4E.
    Proc Natl Acad Sci U S A. 1996 Feb 6;93(3):1065-70 PMID: 8577715
  48. Effect of PML and PML-RAR on the transactivation properties and subcellular distribution of steroid hormone receptors.
    Mol Endocrinol. 1995 Dec;9(12):1791-803 PMID: 8614415
  49. In vivo and in vitro characterization of the B1 and B2 zinc-binding domains from the acute promyelocytic leukemia protooncoprotein PML.
    Proc Natl Acad Sci U S A. 1996 Feb 20;93(4):1601-6 PMID: 8643677
  50. Identification of the gal4 suppressor Sug1 as a subunit of the yeast 26S proteasome.
    Nature. 1996 Feb 15;379(6566):655-7 PMID: 8628401
  51. Exclusion of Int-6 from PML nuclear bodies by binding to the HTLV-I Tax oncoprotein.
    Science. 1996 Aug 16;273(5277):951-3 PMID: 8688078
  52. Nuclear domain 10 (ND10) associated proteins are also present in nuclear bodies and redistribute to hundreds of nuclear sites after stress.
    J Cell Biochem. 1995 Dec;59(4):498-513 PMID: 8749719
  53. The PML nuclear bodies: actors or extras?
    Curr Opin Genet Dev. 1999 Jun;9(3):362-7 PMID: 10377280
  54. Evidence for functional conservation of a mammalian homologue of the light-responsive plant protein COP1.
    Curr Biol. 1999 Jul 1;9(13):711-4 PMID: 10395541
  55. Telomerase-negative immortalized human cells contain a novel type of promyelocytic leukemia (PML) body.
    Cancer Res. 1999 Sep 1;59(17):4175-9 PMID: 10485449
  56. PML is critical for ND10 formation and recruits the PML-interacting protein daxx to this nuclear structure when modified by SUMO-1.
    J Cell Biol. 1999 Oct 18;147(2):221-34 PMID: 10525530
  57. Nuclear domains enriched in RNA 3'-processing factors associate with coiled bodies and histone genes in a cell cycle-dependent manner.
    Mol Biol Cell. 1999 Nov;10(11):3815-24 PMID: 10564273
  58. Localization of the Bloom syndrome helicase to punctate nuclear structures and the nuclear matrix and regulation during the cell cycle: comparison with the Werner's syndrome helicase.
    Mol Carcinog. 1999 Dec;26(4):261-73 PMID: 10569803
  59. Translational regulation of ribonucleotide reductase by eukaryotic initiation factor 4E links protein synthesis to the control of DNA replication.
    J Biol Chem. 1999 Dec 10;274(50):35991-8 PMID: 10585489
  60. The promyelocytic leukemia protein PML interacts with the proline-rich homeodomain protein PRH: a RING may link hematopoiesis and growth control.
    Oncogene. 1999 Nov 25;18(50):7091-100 PMID: 10597310
  61. Triggering of neuronal cell death by accumulation of activated SEK1 on nuclear polyglutamine aggregations in PML bodies.
    Genes Cells. 1999 Dec;4(12):743-56 PMID: 10620019
  62. The distribution and expression of the Bloom's syndrome gene product in normal and neoplastic human cells.
    Br J Cancer. 2001 Jul 20;85(2):261-5 PMID: 11461087
  63. Accumulation and intranuclear distribution of unintegrated human immunodeficiency virus type 1 DNA.
    J Virol. 2001 Aug;75(16):7683-91 PMID: 11462040
  64. Coupled transcription and translation within nuclei of mammalian cells.
    Science. 2001 Aug 10;293(5532):1139-42 PMID: 11423616
  65. PML RING suppresses oncogenic transformation by reducing the affinity of eIF4E for mRNA.
    EMBO J. 2001 Aug 15;20(16):4547-59 PMID: 11500381
  66. Telomerase can inhibit the recombination-based pathway of telomere maintenance in human cells.
    J Biol Chem. 2001 Aug 24;276(34):32198-203 PMID: 11395519
  67. Functional interaction of p53 and BLM DNA helicase in apoptosis.
    J Biol Chem. 2001 Aug 31;276(35):32948-55 PMID: 11399766
  68. Multifunctional regulatory proteins that control gene expression in both the nucleus and the cytoplasm.
    Bioessays. 2001 Sep;23(9):775-87 PMID: 11536290
  69. The acute promyelocytic leukemia-specific PML/RAR alpha fusion protein reduces the frequency of commitment to apoptosis upon growth factor deprivation of GM-CSF-dependent myeloid cells.
    Leukemia. 1995 Sep;9(9):1467-72 PMID: 7658713
  70. Eukaryotic translation initiation factor 4E regulates expression of cyclin D1 at transcriptional and post-transcriptional levels.
    J Biol Chem. 1995 Sep 8;270(36):21176-80 PMID: 7673150
  71. The acute promyelocytic leukaemia-associated PML gene is induced by interferon.
    Oncogene. 1995 Sep 7;11(5):871-6 PMID: 7545807
  72. PIC 1, a novel ubiquitin-like protein which interacts with the PML component of a multiprotein complex that is disrupted in acute promyelocytic leukaemia.
    Oncogene. 1996 Sep 5;13(5):971-82 PMID: 8806687
  73. PML-containing nuclear bodies: their spatial distribution in relation to other nuclear components.
    J Cell Biochem. 1996 Dec 1;63(3):280-91 PMID: 8913879
  74. Characterisation of the PML/RAR alpha rearrangement associated with t(15;17) acute promyelocytic leukaemia.
    Curr Top Microbiol Immunol. 1997;220:81-112 PMID: 9103677
  75. Molecular cloning of a new interferon-induced PML nuclear body-associated protein.
    J Biol Chem. 1997 Aug 1;272(31):19457-63 PMID: 9235947
  76. Ataxin-1 with an expanded glutamine tract alters nuclear matrix-associated structures.
    Nature. 1997 Oct 30;389(6654):971-4 PMID: 9353120
  77. Cell death induction by the acute promyelocytic leukemia-specific PML/RARalpha fusion protein.
    Proc Natl Acad Sci U S A. 1997 Sep 30;94(20):10901-6 PMID: 9380732
  78. The XHex homeobox gene is expressed during development of the vascular endothelium: overexpression leads to an increase in vascular endothelial cell number.
    Mech Dev. 1997 Aug;66(1-2):83-93 PMID: 9376326
  79. Cell-cycle regulation of DNA damage-induced expression of the suppressor gene PML.
    Biochem Biophys Res Commun. 1997 Nov 26;240(3):640-6 PMID: 9398618
  80. The promyelocytic leukemia protein PML has a pro-apoptotic activity mediated through its RING domain.
    FEBS Lett. 1997 Nov 24;418(1-2):30-4 PMID: 9414089
  81. An arenavirus RING (zinc-binding) protein binds the oncoprotein promyelocyte leukemia protein (PML) and relocates PML nuclear bodies to the cytoplasm.
    J Virol. 1998 Jan;72(1):758-66 PMID: 9420283
  82. Transcriptional repression by the promyelocytic leukemia protein, PML.
    Exp Cell Res. 1997 Dec 15;237(2):371-82 PMID: 9434633
  83. The promyelocytic leukemia gene product (PML) forms stable complexes with the retinoblastoma protein.
    Mol Cell Biol. 1998 Feb;18(2):1084-93 PMID: 9448006
  84. Role of PML in cell growth and the retinoic acid pathway.
    Science. 1998 Mar 6;279(5356):1547-51 PMID: 9488655
  85. Two RING finger proteins, the oncoprotein PML and the arenavirus Z protein, colocalize with the nuclear fraction of the ribosomal P proteins.
    J Virol. 1998 May;72(5):3819-26 PMID: 9557665
  86. The mRNA 5' cap-binding protein eIF4E and control of cell growth.
    Curr Opin Cell Biol. 1998 Apr;10(2):268-75 PMID: 9561852
  87. Localization of nascent RNA and CREB binding protein with the PML-containing nuclear body.
    Proc Natl Acad Sci U S A. 1998 Apr 28;95(9):4991-6 PMID: 9560216
  88. Recombinant PML adenovirus suppresses growth and tumorigenicity of human breast cancer cells by inducing G1 cell cycle arrest and apoptosis.
    Oncogene. 1998 Apr 9;16(14):1839-49 PMID: 9583681
  89. SAF-B protein couples transcription and pre-mRNA splicing to SAR/MAR elements.
    Nucleic Acids Res. 1998 Aug 1;26(15):3542-9 PMID: 9671816
  90. Structure, organization, and dynamics of promyelocytic leukemia protein nuclear bodies.
    Am J Hum Genet. 1998 Aug;63(2):297-304 PMID: 9683622
  91. Demonstration of a RNA-dependent nuclear interaction between the promyelocytic leukaemia protein and glyceraldehyde-3-phosphate dehydrogenase.
    Biochem J. 1998 Nov 1;335 ( Pt 3):691-6 PMID: 9794812
  92. PML induces a novel caspase-independent death process.
    Nat Genet. 1998 Nov;20(3):259-65 PMID: 9806544
  93. PML is essential for multiple apoptotic pathways.
    Nat Genet. 1998 Nov;20(3):266-72 PMID: 9806545
  94. SUMO-1 modification of the acute promyelocytic leukaemia protein PML: implications for nuclear localisation.
    J Cell Sci. 1999 Feb;112 ( Pt 3):381-93 PMID: 9885291
  95. Evidence for proteasome involvement in polyglutamine disease: localization to nuclear inclusions in SCA3/MJD and suppression of polyglutamine aggregation in vitro.
    Hum Mol Genet. 1999 Apr;8(4):673-82 PMID: 10072437
  96. The RING domains of the promyelocytic leukemia protein PML and the arenaviral protein Z repress translation by directly inhibiting translation initiation factor eIF4E.
    J Mol Biol. 2001 Sep 28;312(4):609-23 PMID: 11575918
  97. PML protein isoforms and the RBCC/TRIM motif.
    Oncogene. 2001 Oct 29;20(49):7223-33 PMID: 11704850
  98. DNA viruses and viral proteins that interact with PML nuclear bodies.
    Oncogene. 2001 Oct 29;20(49):7266-73 PMID: 11704855
  99. Role and fate of PML nuclear bodies in response to interferon and viral infections.
    Oncogene. 2001 Oct 29;20(49):7274-86 PMID: 11704856
  100. Maturation sensitive and resistant t(15;17) NB4 cell lines as tools for APL physiopathology: nomenclature of cells and repertory of their known genetic alterations and phenotypes.
    Oncogene. 2001 Oct 29;20(49):7287-91 PMID: 11704857
  101. PML bodies associate specifically with the MHC gene cluster in interphase nuclei.
    J Cell Sci. 2001 Oct;114(Pt 20):3705-16 PMID: 11707522
  102. Self-assembly properties of a model RING domain.
    Proc Natl Acad Sci U S A. 2002 Jan 22;99(2):667-72 PMID: 11792829
  103. Metabolic-energy-dependent movement of PML bodies within the mammalian cell nucleus.
    Nat Cell Biol. 2002 Feb;4(2):106-10 PMID: 11753375
  104. The emerging roles of translation factor eIF4E in the nucleus.
    Differentiation. 2002 Mar;70(1):10-22 PMID: 11963652
  105. Gamma interferon and cadmium treatments modulate eukaryotic initiation factor 4E-dependent mRNA transport of cyclin D1 in a PML-dependent manner.
    Mol Cell Biol. 2002 Sep;22(17):6183-98 PMID: 12167712
  106. The C-terminal domain of the Bloom syndrome DNA helicase is essential for genomic stability.
    BMC Cell Biol. 2001;2:11 PMID: 11472631
  107. Construction of macromolecular assemblages in eukaryotic processes and their role in human disease: linking RINGs together.
    Curr Protein Pept Sci. 2000 Jul;1(1):49-73 PMID: 12369920
Article Info
Journal
Molecular and cellular biology
Abbr.
Mol Cell Biol
ISSN
0270-7306
DOI
10.1128/MCB.22.15.5259-5269.2002
Email
kathy@physbio.mssm.edu
Published
2002-08-00
Pages
5259-69
Language
English
Region
United States
NLM ID
8109087
PMCID
PMC133952
Subset
IM
Grants
NCI NIH HHS · R01 CA080728 · United States
NCI NIH HHS · R01 CA088991 · United States
NCI NIH HHS · CA 80728 · United States
NCI NIH HHS · CA 88991 · United States
External Links
PubMed source DOI: 10.1128/MCB.22.15.5259-5269.2002 PMC Full Text View journal details
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com

Copyright © 2026.Genelibs Jinan Honghui Biotechnology Co., Ltd. 鲁ICP备20007159号-2